Baicalin 95% CAS:21967-41-9 Manufacturer Supplier
Baicalin has been used in a study to examine its neuroprotective effect in chronically stressed rats.Baicalin is mainly used as the adjuvant therapy for acute and chronic hepatitis and persistent hepatitis. Baicalin was shown to reduce the expression of hepatitis B surface antigen, e antigen and the core antigen, and inhibited hepatitis B virus DNA replication. Reduced serum alanine aminotransferase level was observed in hepatitis patient treated with baicalin, and other liver function indexes were also found to be improved. No adverse reactions about baicalin have been reported. In addition, baicalin was reported to treat early diabetic nephropathy and alleviate the symptoms of diabetic neuropathy.As one of the antimicrobial components of Scutellaria baicalensis, eye drops containing 3% baicalin are used clinically in the treatment of trachoma, with the similar curative effect as rifampicin.
Composition | C21H18O11 |
Assay | 95% |
Appearance | Pale Yellow to Yellow powder |
CAS No. | 21967-41-9 |
Packing | 25KG |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |